Clinical Evaluation of OSNA Breast Cancer System in Breast Cancer Patients Receiving Neoadjuvant Therapy



Status:Archived
Conditions:Breast Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:July 2010
End Date:July 2012

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

OSNA Neoadjuvant Feasibility Study in Breast Cancer Patients


The study will determine the sensitivity, specificity, negative predictive value and
positive predictive value of the OSNA Breast Cancer System for patients receiving Sentinel
Lymph Node biopsies after receiving neoadjuvant hormonal/chemotherapy as compared to
permanent section Hematoxylin and Eosin (H&E) and Immuno-histochemistry (IHC) staining.



We found this trial at
2
sites
University of Texas M.D. Anderson Cancer Center
1515 Holcombe Blvd
Houston, Texas 77030
 713-792-2121
University of Texas M.D. Anderson Cancer Center The mission of The University of Texas MD...
?
mi
from
Houston, TX
Click here to add this to my saved trials
Arizona Cancer Center, University of Arizona
Tucson, Arizona 85724
?
mi
from
Tucson, AZ
Click here to add this to my saved trials